FrancophonIA/ELRC3.0 huggingface dataset:
English: Psychiatric disorders insomnia confusion and disorientation, depression, anxiety symptoms, hallucination, mental disorders, depressed mood, mood disorders and disturbances, nightmare psychotic disorder
Croatian: Psihijatrijski poremećaji nesanica smetenost i dezorijentiranost, depresija, simptomi anksioznosti, halucinacije, mentalni poremećaji,
English: Dosing should primarily be based on clinical assessments of rejection and tolerability in each individual patient aided by whole blood tacrolimus trough level monitoring.
Croatian: Doziranje se u prvom redu treba temeljiti na kliničkoj procjeni odbacivanja presatka i podnošljivosti lijeka u svakog pojedinog bolesnika, uz pomoć praćenja najnižih koncentracija takrolimusa u punoj krvi.
English: Magnesium stearate Tartaric acid (E334) Butylated hydroxytoluene (E321) Dimethicone 350
Croatian: 6.1 Popis pomoćnih tvari hipromeloza laktoza hidrat makrogol 6000 poloksamer 188 magnezijev stearat tartaratna kiselina (E334) butilhidroksitoluen (E321) dimetikon 350
English: The efficacy and safety of Envarsus and Prograf, both in combination with mycophenolate mofetil (MMF) or mycophenolate sodium (MPS) and corticosteroids, were compared in 324 stable kidney transplant recipients.
Croatian: Djelotvornost i sigurnost Envarsusa i Prografa, oba u kombinaciji s mikofenolat mofetilom ili mikofenolatnatrijem i kortikosteroidima, uspoređene su u 324 stabilna primatelja presatka bubrega.
English: As tacrolimus is a substance with low clearance, adjustments to the dose regimen may take several days before steady state is achieved.
Croatian: Budući da je takrolimus tvar s niskim klirensom, nakon prilagodbe režima doziranja može proći i nekoliko dana prije nego se postigne stanje dinamičke ravnoteže.
English: 30 prolonged-release tablets 60 prolonged-release tablets 90 prolonged-release tablets
Croatian: 30 tableta s produljenim oslobađanjem 60 tableta s produljenim oslobađanjem 90 tableta s produljenim oslobađanjem
English: In comparison to Caucasians, black patients may require higher tacrolimus doses to achieve similar trough levels.
Croatian: U odnosu na bijelu rasu, u bolesnika crne rase mogu biti potrebne više doze takrolimusa da bi se postigle slične vrijednosti najniže koncentracije.
English: Following conversion to any alternative formulation, therapeutic drug monitoring must be performed and dose adjustments made to ensure that systemic exposure to tacrolimus is maintained.
Croatian: Nakon zamjene jednog farmaceutskog oblika drugim, potrebno je tijekom liječenja pratiti koncentraciju lijeka i prilagođavati dozu kako bi se održala jednaka sustavna izloženost takrolimusu.
English: For these reasons, the combined administration of ciclosporin and tacrolimus is not recommended, and care should be taken when administering tacrolimus to patients who have previously received ciclosporin (see sections 4.2 and 4.4).
Croatian: Stoga, ne preporučuje se kombinirana primjena ciklosporina i takrolimusa, te je potreban oprez kada se takrolimus primjenjuje u bolesnika koji su prethodno uzimali ciklosporin (vidjeti dijelove 4.2 i 4.4).
English: The event rate for locally read BPAR during the 360-day study was 1.2% in the Envarsus group (N=162) post conversion from Prograf at a dose ratio of 1:0.7 (mg:mg) and 1.2% in the group maintained on Prograf (N=162).
Croatian: Stopa lokalno interpretirane akutne reakcije odbacivanja potvrđene biopsijom (BPAR), tijekom 360 dana ispitivanja iznosila je 1,2% u skupini koja je primala Envarsus (N=162) nakon prebacivanja s Prografa u omjeru doza od 1: 0,7 (mg:mg) i 1,2% u skupini koja je zadržana na Prografu (N=162).
English: diltiazem and verapamil) - anti-arrhythmic substances (e.g. amiodarone) used to control arrhythmia (uneven beating of the heart)
Croatian: nikardipin, diltiazem i verapamil) - antiaritmike (primjerice, amiodaron) koji se primjenjuju za kontrolu aritmija
English: Treatment emergent fatal adverse events occurred in 1.2% of Envarsus patients and 0.6% of Prograf patients.
Croatian: Štetni događaji sa smrtnim ishodom tijekom liječenja dogodili su se u 1,2% bolesnika koji su uzimali Envarsus i u 0,6% bolesnika koji su uzimali Prograf.
English: Patients treated with tacrolimus have been reported to develop Epstein-Barr Virus (EBV)-associated lymphoproliferative disorders (see section 4.8).
Croatian: Epstein-Barr virusom (EBV) (vidjeti dio 4.8).
English: During the initial post-transplant period, monitoring of the following parameters should be undertaken on a routine basis: blood pressure, ECG, neurological and visual status, fasting blood glucose levels, electrolytes (particularly potassium), liver and renal function tests, haematology parameters, coagulation values, and plasma protein determinations.
Croatian: krvni tlak, EKG, neurološki status i status vida, koncentracija glukoze u krvi natašte, elektroliti (osobito kalij), testovi funkcije jetre i bubrega, hematološki parametri te vrijednosti koagulacije i određivanje proteina plazme.
English: Cardiac disorders ischaemic coronary artery disorders, tachycardia heart failures, ventricular arrhythmias and cardiac arrest, supraventricular arrhythmias, cardiomyopathies, ventricular hypertrophy, palpitations pericardial effusion
Croatian: Srčani poremećaji ishemijska bolest koronarnih arterija, tahikardija zatajenje srca, ventrikularne aritmije i zastoj srca, supraventrikularne aritmije, kardiomiopatije, ventrikularna hipertrofija, palpitacije perikardijalni izljev
English: Patients should be advised to report changes in visual acuity, changes in colour vision, blurred vision, or visual field defect, and in such cases, prompt evaluation is recommended with referral to an ophthalmologist as appropriate.
Croatian: Bolesnike treba uputiti da prijave promjene oštrine vida, promjene vida u boji, zamagljen vid ili poremećaje vidnog polja.
English: The combined administration of ciclosporin and tacrolimus should be avoided and care should be taken when administering tacrolimus to patients who have previously received ciclosporin (see sections 4.2 and 4.5).
Croatian: Treba izbjegavati kombiniranu primjenu ciklosporina i takrolimusa, a oprez je potreban i kada se takrolimus primjenjuje u bolesnika koji su prethodno uzimali ciklosporin (vidjeti dijelove 4.2 i 4.5).
English: Envarsus contains the active substance tacrolimus.
Croatian: Envarsus sadrži djelatnu tvar takrolimus.
English: Tacrolimus has been shown to increase the blood level of phenytoin.
Croatian: Pokazano je da takrolimus povećava razinu fenitoina u krvi.
English: Do not swallow the desiccant contained in the foil wrapper.
Croatian: Nemojte progutati sredstvo za sušenje koje se nalazi u zaštitnom omotu.
English: Treatment of allograft rejection after kidney or liver transplantation For conversion from other immunosuppressants to once daily tacrolimus, treatment should begin with the initial oral dose recommended in kidney and liver transplantation respectively for prophylaxis of transplant rejection.
Croatian: Kad se drugi imunosupresivi zamjenjuju takrolimusom koji se uzima jedanput na dan, liječenje je potrebno započeti početnom peroralnom dozom Envarsusa koja se preporučuje za sprječavanje odbacivanja presatka nakon presađivanja bubrega odnosno jetre.
English: This can lead to graft rejection or increased incidence of adverse reactions, including under- or overimmunosuppression, due to clinically relevant differences in systemic exposure to tacrolimus.
Croatian: uključujući nedovoljnu ili prekomjernu imunosupresiju, zbog klinički značajnih razlika u sustavnoj izloženosti takrolimusu.
English: High potassium intake or potassium-sparing diuretics should be avoided (see section 4.5).
Croatian: Potrebno je izbjegavati uzimanje velikih količina kalija ili diuretika koji štede kalij (vidjeti dio 4.5).
English: • Summary of Product Characteristics and Patient Information Leaflet
Croatian: • Sažetak opisa svojstva lijeka i uputu o lijeku
English: Prophylaxis of transplant rejection in adult kidney or liver allograft recipients.
Croatian: Sprječavanje reakcija odbacivanja transplantata u odraslih primatelja alogenih presadaka bubrega ili jetre.
English: Some cases have reported resolution on switching to alternative immunosuppression.
Croatian: U nekim je slučajevima prijavljeno povlačenje poremećaja nakon prelaska na drugu imunosupresivnu terapiju.
English: There is a risk for premature delivery (<37 week) (incidence of 66 of 123 births, i.e. 53.7%; however, data showed that the majority of the newborns had normal birth weight for their gestational age) as well as for hyperkalaemia in the newborn (incidence 8 of 111 neonates, i.e. 7.2 %) which, however normalises spontaneously.
Croatian: međutim podaci ukazuju da je većina novorođene djece imala normalnu težinu po porodu za svoju gestacijsku dob) kao i za hiperkalijemiju kod novorođenčadi (incidencija 8 od 111
English: Following the initiation of your treatment with this medicine, frequent blood tests will be taken by your doctor to define the correct dose.
Croatian: U početku liječenja ovim lijekom bit će potrebno provođenje redovitih krvnih pretraga, koje će tražiti
English: • Patient cards to be given to patients with the product
Croatian: • Bolesnicima se zajedno s lijekom trebaju izdati i kartice za bolesnike
English: It is an immunosuppressant.
Croatian: Envarsus je imunosupresivni lijek.
English: Treatment-emergent fatal adverse events occurred in 1.8% of Envarsus patients and 2.5% of Prograf patients.
Croatian: Štetni događaji sa smrtnim ishodom tijekom liječenja dogodili su se u 1,8% bolesnika koji su uzimali Envarsus i u 2,5% bolesnika koji su uzimali Prograf.
English: Symptoms have included tremor, headache, nausea and vomiting, infections, urticaria, lethargy and increases in blood urea nitrogen, serum creatinine and alanine aminotransferase levels.
Croatian: urtikariju, letargiju i povišene razine dušika iz ureje u krvi, kreatinina u serumu i alanin aminotransferaze.
English: Nervous system disorders headache, tremor nervous system disorders seizures, disturbances in consciousness, peripheral neuropathies, dizziness, paraesthesias and dysaesthesias, writing impaired encephalopathy, central nervous system haemorrhages and cerebrovascular accidents, coma, speech and language ab-normalities, paralysis and paresis, amnesia hypertonia myasthenia
Croatian: Poremećaji živčanog sustava glavobolja, tremor epizode poremećaja živčanog sustava, poremećaji svijesti, periferne neuropatije, omaglica, parestezije i dizestezije, narušena sposobnost pisanja encefalopatija, krvarenja u središnjem živčanom sustavu i cerebrovaskularni incidenti, koma,
English: Do not drive or use any tools or machines if you feel dizzy or sleepy, or have problems seeing clearly after taking Envarsus.
Croatian: Ako nakon uzimanja Envarsusa imate omaglicu, osjećate pospanost ili Vam je zamućen vid, nemojte voziti, koristiti alate ili upravljati strojevima.
English: Rare side effects (may affect up to 1 in 1,000 people): - Small bleedings in your skin due to blood clots - Increased muscle stiffness - Blindness, deafness
Croatian: Rijetke nuspojave (mogu se pojaviti u do 1 na 1000 osoba): - sitna krvarenja u koži zbog krvnih ugrušaka
English: Chiesi España, S.A.U.
Croatian: Chiesi S.A.S.
English: Envarsus 0.75 mg prolonged-release tablets are oval, white to off-white uncoated tablet, debossed with “0.75” on one side and “TCS” on the other side.
Croatian: Envarsus 0,75 mg tablete s produljenim oslobađanjem su ovalne, bijele do bjelkaste neobložene tablete, s utisnutom oznakom „0.75“ na jednoj strani i „TCS“ na drugoj strani.
English: Human data show that tacrolimus crosses the placenta.
Croatian: Podaci iz ispitivanja provedenih u ljudi pokazuju da takrolimus prolazi kroz posteljicu.
English: Skin and subcutaneous tissue disorders rash, pruritus, alopecias, acne, sweating increased dermatitis, photosensitivity toxic epidermal necrolysis (Lyell's syndrome)
Croatian: pojačano znojenje dermatitis, fotoosenzitiv nost toksična epidermalna nekroliza (Lyellov sindrom)
English: Inadvertent, unintentional, or unsupervised switching of immediate- or prolonged-release formulations of tacrolimus is unsafe.
Croatian: Nepažljivo, nenamjerno ili nenadzirano mijenjanje farmaceutskih oblika takrolimusa s trenutnim oslobađanjem s farmaceutskim oblikom takrolimusa s produljenim oslobađanjem nije sigurno.
English: Musculoskeletal and connective tissue disorders arthralgia, back pain, muscle cramps, pain in limb joint disorders mobility decreased
Croatian: Poremećaji mišićno koštanog sustava i vezivnog tkiva artralgija, bol u leđima, grčevi u mišićima, bol u udovima poremećaji zglobova smanjena pokretljivost
English: Allograft transplant patients maintained on twice daily Prograf (immediate-release) or Advagraf (once daily) dosing requiring conversion to once daily Envarsus should be converted on a 1:0.7 (mg:mg)
Croatian: U bolesnika s alogenim presatkom koji uzimaju Prograf (s trenutnim oslobađanjem) dva puta na dan ili Advagraf (jedanput na dan), a moraju prijeći na Envarsus koji se uzima jedanput na dan, prelazak treba biti u omjeru ukupne dnevne doze 1: 0,7 (mg:mg), stoga doza održavanja Envarsusa treba biti 30% manja od doze Prografa ili Advagrafa.
English: The kidneys and the pancreas were the primary organs affected in toxicity studies performed in rats and baboons.
Croatian: U ispitivanjima toksičnosti koja su provedena u štakora i babuna, primarno su bili zahvaćeni bubrezi i gušterača.
English: Medication errors, including inadvertent, unintentional or unsupervised substitution of immediate- or prolonged-release tacrolimus formulations, have been observed.
Croatian: Primijećene su medikacijske pogreške, uključujući nepažljivo, nenamjerno ili nenadzirano mijenjanje farmaceutskih oblika takrolimusa s trenutnim oslobađanjem s onima s produljenim oslobađanjem.
English: Oval, white to off-white uncoated tablet, debossed with “0.75” on one side and “TCS” on the other side.
Croatian: Ovalna, bijela do bjelkasta neobložena tableta, s utisnutom oznakom „0.75“ na jednoj strani i „TCS“ na drugoj strani.
English: Metabolism and nutrition disorders diabetes mellitus, hyperglycaemic conditions, hyperkalaemia anorexia, metabolic acidoses, other electrolyte abnormalities, hyponatraemia, fluid overload, hyperuricaemia, hypomagnesaemia, hypokalaemia, hypocalcemia, appetite decreased, hypercholesterolaemia, hyperlipidaemia, hypertriglyceridaemia, hypophosphateaemia dehydration, hypoglycaemia, hypoproteinaemia, hyperphosphataemia
Croatian: hiperuricemija, hipomagnezijemija, hipokalijemija, hipokalcijemija smanjen tek, hiperkolesterolemija, hiperlipidemija, hipertrigliceridemija, hipofosfatemija dehidracija, hipoglikemija, hipoproteinemija, hiperfosfatemija
English: CYP3A4 inhibitors potentially leading to increased tacrolimus blood levels Clinically, the following substances have been shown to increase tacrolimus blood levels: Strong interactions have been observed with antifungal agents such as ketoconazole, fluconazole, itraconazole, voriconazole and isavuconazole, the macrolide antibiotic erythromycin, HIV protease inhibitors (e.g. ritonavir, nelfinavir, saquinavir) or Hepatitis C Virus (HCV) protease inhibitors (e.g. telaprevir, boceprevir, and the combination of ombitasvir and paritaprevir with ritonavir, when used with and without dasabuvir), the pharmacokinetic enhancer cobicistat, and the tyrosine kinase inhibitors nilotinib and imatinib.
Croatian: Opažene su jake interakcije s antimikoticima poput ketokonazola, flukonazola, itrakonazola, vorikonazola i izavukonazola, s makrolidnim antibiotikom eritromicinom, inhibitorima proteaze HIV-a (npr. ritonavirom, nelfinavirom, sakvinavirom), inhibitorima proteaze HCV-a (npr. telaprevirom, boceprevirom i kombinacijom ombitasvira i paritaprevira s ritonavirom, primijenjenom s dasabuvirom ili bez njega), farmakokinetičkim pojačivačem kobicistatom te inhibitorima tirozin-kinaze nilotinibom i imatinibom.
English: Talk to your doctor before taking Envarsus: - if you have, or have had, liver problems.
Croatian: Obratite se svom liječniku prije nego uzmete Envarsus: - ako imate ili ste imali problema s jetrom - ako imate proljev koji traje dulje od jednog dana - ako uzimate bilo koji od lijekova navedenih pod „Drugi lijekovi i Envarsus“ - ako imate poremećaj električne aktivnosti srca koji se zove „produljenje QT-intervala“.
English: Envarsus 0.75 mg prolonged-release tablets Envarsus 1 mg prolonged-release tablets Envarsus 4 mg prolonged-release tablets
Croatian: Envarsus 0,75 mg tablete s produljenim oslobađanjem Envarsus 1 mg tablete s produljenim oslobađanjem Envarsus 4 mg tablete s produljenim oslobađanjem
English: Prophylaxis of liver transplant rejection
Croatian: Sprječavanje odbacivanja presatka jetre
English: Eye disorders, sometimes progressing to loss of vision, have been reported in patients treated with tacrolimus.
Croatian: U bolesnika liječenih takrolimusom prijavljeni su poremećaji oka, koji su ponekad uznapredovali do gubitka vida.
English: Hepatobiliary disorders bile duct disorders, hepatocellular damage and hepatitis, cholestasis and jaundice venoocclusive liver disease, hepatic artery thrombosis hepatic failure
Croatian: hepatocelularno oštećenje i hepatitis, kolestaza i žutica venookluzivna bolest jetre, tromboza arterije jetre zatajenje jetre
English: The event rate of biopsy-confirmed acute rejection within the 360-day study period was not significantly different between the Envarsus group and the tacrolimus immediate-release group.
Croatian: Stopa akutne reakcije odbacivanja presatka potvrđena biopsijom tijekom 360 dana ispitivanja nije se značajno razlikovala između skupine liječene
English: These may worsen kidney or nervous system problems when taken together with Envarsus.
Croatian: Ako se uzmu zajedno s Envarsusom, ti lijekovi mogu pogoršati probleme s bubrezima ili živčanim sustavom.
English: Tel: + 34 93 494 8000
Croatian: Chiesi España, S.A.U Tel: + 34 93 494 8000
English: All patients reported risk factors for PRCA such as parvovirus B19 infection, underlying disease or concomitant medicinal product associated with PRCA.
Croatian: kao što je infekcija parvovirusom B19, podležeća bolest ili istodobno uzimanje lijekova koji su povezani s nastankom PRCA.
English: Investigations liver function tests abnormal blood alkaline phosphatase increased, weight increased amylase increased, ECG abnormal, heart rate and pulse investigations abnormal, weight decreased, blood lactate dehydrogenase increased echocardiogram abnormal,
Croatian: Pretrage poremećeni nalazi testova jetrene funkcije povišena razina alkalne fosfataze u krvi, povećanje tjelesne težine povišena razina amilaze,
English: - if you are allergic to sirolimus or to any macrolide-antibiotic (e.g. erythromycin, clarithromycin, josamycin).
Croatian: - ako ste alergični na takrolimus ili neki drugi sastojak ovog lijeka (naveden u dijelu 6.). - ako ste alergični na sirolimus ili neki makrolidni antibiotik (npr. eritromicin,
English: Oval, white to off-white uncoated tablet, debossed with “1” on one side and “TCS” on the other side.
Croatian: Ovalna, bijela do bjelkasta neobložena tableta, s utisnutom oznakom „1“ na jednoj strani i „TCS“ na drugoj strani.
English: Chiesi Pharmaceuticals B.V. Tel: + + 31 0 88 5016400
Croatian: Tel: + 31 0 88 5016400
English: In isolated patients with very high plasma levels, haemofiltration or -diafiltration have been effective in reducing toxic concentrations.
Croatian: Hemofiltracija ili hemodijafiltarcija bile su učinkovite u smanjivanju toksičnih koncentracija u izoliranim slučajevima bolesnika s vrlo visokom razinom u plazmi.
English: If patients taking tacrolimus present with symptoms indicating PRES such as headache, altered mental status, seizures and visual disturbances, a radiological procedure (e.g. MRI) should be performed.
Croatian: Ako se u bolesnika koji uzimaju takrolimus pojave simptomi koji ukazuju na PRES, kao što su glavobolja,
English: Based on its high molecular weight, poor aqueous solubility, and extensive erythrocyte and plasma protein binding, it is anticipated that tacrolimus will not be dialysable.
Croatian: Pretpostavlja se da se takrolimus ne može ukloniti dijalizom zbog svoje visoke molekularne težine, slabe topljivosti u vodi i vezanja u velikoj mjeri za eritrocite i proteine plazme.
English: Envarsus 0.75 mg prolonged-release tablets tacrolimus
Croatian: Envarsus 0,75 mg tablete s produljenim oslobađanjem tacrolimus
English: Envarsus 1 mg prolonged-release tablets are oval, white to off-white uncoated tablet, debossed with “1” on one side and “TCS” on the other side
Croatian: Envarsus 1 mg tablete s produljenim oslobađanjem su ovalne, bijele do bjelkaste neobložene tablete, s utisnutom oznakom „1“ na jednoj strani i „TCS“ na drugoj strani.
English: Envarsus 0.75 mg prolonged-release tablets
Croatian: Envarsus 0,75 mg tablete s produljenim oslobađanjem
English: Envarsus 4 mg prolonged-release tablets are oval, white to off-white uncoated tablet, debossed with “4” on one side and “TCS” on the other side.
Croatian: Envarsus 4 mg tablete s produljenim oslobađanjem su ovalne, bijele do bjelkaste neobložene tablete, s utisnutom oznakom „4“ na jednoj strani i „TCS“ na drugoj strani.
English: Lansoprazol and ciclosporin may potentially inhibit CYP3A4-mediated metabolism of tacrolimus and, thereby, increase tacrolimus whole blood concentrations.
Croatian: CYP3A4 i time povećati koncentraciju takrolimusa u punoj krvi.
English: Make sure that you receive the same tacrolimus medicine every time you collect your prescription, unless your transplant specialist has agreed to change to a different tacrolimus medicine.
Croatian: Pazite da Vam pri svakom podizanju lijeka na recept dobijete isti lijek koji sadrži takrolimus,
English: In all, there appears to be no significant difference in the pattern of adverse events suspected to be causally related to study drug between once daily Envarsus and tacrolimus immediate-release capsules (Prograf).
Croatian: Općenito, čini se da između Envarsusa primijenjenog jedanput na dan i kapsula takrolimusa s trenutnim oslobađanjem (Prograf) nema značajne razlike u uzorku štetnih događaja za koje se sumnja da su uzročno povezani s ispitivanim lijekom.
English: Cases of BK virus associated nephropathy, as well as cases of JC virus associated progressive multifocal leukoencephalopathy (PML), have been reported in patients treated with immunosuppressants, including tacrolimus.
Croatian: U bolesnika liječenih imunosupresivima, uključujući takrolimus, prijavljeni su slučajevi nefropatije povezane s BK virusom kao i slučajevi progresivne multifokalne leukoencefalopatije
English: The relationship between tacrolimus trough levels (C24) and systemic exposure (AUC0-24) for Envarsus is similar to that of immediate-release tacrolimus.
Croatian: (AUC0-24) za Envarsus sličan je onome za takrolimus s trenutnim oslobađanjem.
English: Blood and lymphatic system disorders anaemia, thrombocytopenia, leukopenia, red blood cell analyses abnormal, leukocytosis coagulopathies, pancytopenia, neutropenia, coagulation and bleeding analyses, abnormal thrombotic thrombocytopenic purpura, hypoprothrombinaemia, thrombotic microangiopathy pure red cell aplasia, agranulocytosis, haemolytic anaemia
Croatian: poremećaj testova koagulacije i krvarenja trombotska trombocito penična purpura, hipoprotrombinemija, trombotska mikroangiopatija izolirana aplazija crvene krvne loze, agranulocitoza,
English: Each prolonged-release tablet contains 0.75 mg tacrolimus (as monohydrate).
Croatian: Jedna tableta s produljenim oslobađanjem sadrži 0,75 mg takrolimusa (tacrolimus) (u obliku hidrata).
English: fever, nausea or vomiting - an infection, leading to problems with your kidney or neurological symptoms - headache, altered mental status, seizures and visual disturbances - weakness, change in skin or eye colour, easy bruising, infection, cough, anaemia
Croatian: - glavobolju, promijenjeno mentalno stanje, napadaje i poremećaje vida - slabost, promjenjenu boju kože ili bjeloočnica, sklonost nastanku modrica, infekciju,
English: Envarsus 4 mg prolonged-release tablets tacrolimus
Croatian: Envarsus 4 mg tablete s produljenim oslobađanjem tacrolimus